ZAMRA clarifies on suspected defective BP tablets
Published On November 14, 2023 » 985 Views» By Times Reporter » Latest News
 0 stars
Register to vote!

THE Zambia Medicines Regulatory Authority (ZAMRA) and the Zambia Medicines and Medical Supplies Agency (ZAMMSA) have assured that the Erythromycin Stearate, Blood Pressure (BP) tablets, which were suspected to be defective were not distributed to public health facilities countrywide but quarantined to pave way for further tests and investigations.
Read more

Share this post

About The Author